Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994–2009

Sara Rosengren,U-H Mellqvist,Hareth Nahi,Karin Forsberg,Stig Lenhoff,O Stromberg,Lucia Ahlberg,Olle Linder,Kristina Carlson

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994–2009

2016

Sara Rosengren
U-H Mellqvist
Hareth Nahi
Karin Forsberg
Stig Lenhoff
O Stromberg
Lucia Ahlberg
Olle Linder
Kristina Carlson

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994–2009

Keywords:

Immunology
Diabetes mellitus
AL amyloidosis
Progenitor cell
Graft-versus-host disease
Stem cell
Medicine
Transplantation
Melphalan
Autologous stem-cell transplantation
Pathology
Amyloidosis
Hematopoietic stem cell transplantation
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations